logo
Plus   Neg
Share
Email

Dr. Reddy's Partners With FUJIFILM, Global Response Aid For Avigan Tablets - Quick Facts

Dr. Reddy's Laboratories Ltd. (RDY) said it partnered with FUJIFILM Corporation through FUJIFILM Toyama Chemical Co. Ltd. and Global Response Aid for the development, manufacture and sales of Avigan Tablets, a potential treatment of COVID-19.

Under the tripartite agreement signed on 30th June 2020, FUJIFILM granted Dr. Reddy's the exclusive rights of manufacturing and also granted both Dr. Reddy's and GRA the rights to develop, sell and distribute Avigan in all countries other than Japan, China and Russia.

Dr. Reddy noted that it would have exclusive rights for development, selling and distribution of Avigan in India. Further, FUJIFILM would receive an upfront license fee and royalties on sales from Dr. Reddy's and GRA.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Securities and Exchange Commission is investigating the circumstances around Eastman Kodak Co.'s (KODK) announcement of a $765 million government loan to make ingredients for Covid-19 drugs, the Wall Street Journal reported citing people familiar with the matter. The National Retail Federation or NRF said that conflicting economic data amid a resurgence in coronavirus cases has made it difficult to predict how steadily the U.S. economic recovery will continue. NRF Chief Economist Jack Kleinhenz noted that based on quarterly and monthly data, the U.S. economic recovery is continuing despite the elevated COVID-19 cases. Ford Motor Company (F) announced that Jim Hackett plans to retire as President and CEO. He will continue as a special advisor to the company through March of 2021. The company has named Jim Farley as new president and CEO. He will join the board of directors, effective Oct. 1. Farley joined Ford in...
Follow RTT